Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 5901–5950 of 35159
On and effective November 26, 2024 , Holly Hess Groos was appointed to serve as a member of the board of directors (“the Board”) of DIRTT Environmental Solutions Ltd. (“DIRTT” or the “Company”).
On November 25, 2024, the Board of Directors (the “Board”) of Open Text Corporation (“OpenText”) appointed Fletcher Previn to its board of directors.
On November 20, 2024, Clearway Energy, Inc. (the “ Company ”) received a notice of resignation from Guillaume Hédiard, informing the Company of his intention to resign from the board of directors (the “ Board ”) of the Company effective as of the close of business on December 4, 2024.
On November 22, 2024, Hans Bishop resigned as a member of the Board of Directors (the “Board”) and the Nominating and Corporate Governance Committee of the Board of Lyell Immunopharma, Inc. (the “Company”).
On November 22, 2024, Jeffrey M. Jonas, MD, a member of the Board of Directors (the “Board”) of Sage Therapeutics, Inc. (the “Company”), notified the Company of his retirement from the Board, effective as of December 1, 2024.
On November 24, 2024, Daniel Steefel notified the Company of his resignation as a member of the Board and the audit committee of the Board, effective as of that date.
On the Closing Date, in connection with the closing of the Offering, each of Troy Alstead and Andrew Varga joined the Board of Directors of the Company.
On the Closing Date, in connection with the closing of the Offering, each of Troy Alstead and Andrew Varga joined the Board of Directors of the Company.
On November 21, 2024, Gary D. Owens notified Geospace Technologies Corporation (the “Company”) that he will not seek re-election to the Company” board of directors (the “Board”).
filled the vacancy thus created with Charles Tamburello, who will serve from December 1, 2024, until the next annual meeting of shareholders.
Bard Rockenbach and James Melvin resigned as directors of Twin Vee and any committees thereof.
Marcia Kull was appointed as a director of Twin Vee.
Bard Rockenbach and James Melvin resigned as directors of Twin Vee and any committees thereof.
at the Effective Time, Marcia Kull, Neill Ross and Kevin Schuyler resigned as directors of Forza.
at the Effective Time, Marcia Kull, Neill Ross and Kevin Schuyler resigned as directors of Forza.
at the Effective Time, Marcia Kull, Neill Ross and Kevin Schuyler resigned as directors of Forza.
Mr. Portillo will also be appointed as a member of the Board, effective November 25, 2024.
On November 26, 2024, the Company’s Board of Directors appointed Jianguo Geng to serve as a member of the Company’s Board of Director.
On November 26, 2024, the Board of Directors (the “ Board ”) of Douglas Elliman Inc. (the “ Company ”) appointed Scott Vogel as a Class III director to the Board to fill an existing vacancy on the Board.
On November 25, 2024, George H. (Trey) Henderson, III, a member of the Board of Directors of Southside Bancshares, Inc. (the “Company”), notified the Company of his decision to not stand for re-election at the Company’s next annual shareholder meeting in May 2025 (the “2025 Annual Meeting”).
as a result of the Merger, at the Effective Time, each of Luis Aguilar, Gayle Crowell, Valerie Mosley, Gregory Smith, Lauren Taylor Wolfe and Barbara Turner resigned from the Board and any committees of the Board on which they served and ceased to be directors of the Company
as a result of the Merger, at the Effective Time, each of Luis Aguilar, Gayle Crowell, Valerie Mosley, Gregory Smith, Lauren Taylor Wolfe and Barbara Turner resigned from the Board and any committees of the Board on which they served and ceased to be directors of the Company
as a result of the Merger, at the Effective Time, each of Luis Aguilar, Gayle Crowell, Valerie Mosley, Gregory Smith, Lauren Taylor Wolfe and Barbara Turner resigned from the Board and any committees of the Board on which they served and ceased to be directors of the Company
as a result of the Merger, at the Effective Time, each of Luis Aguilar, Gayle Crowell, Valerie Mosley, Gregory Smith, Lauren Taylor Wolfe and Barbara Turner resigned from the Board and any committees of the Board on which they served and ceased to be directors of the Company
as a result of the Merger, at the Effective Time, each of Luis Aguilar, Gayle Crowell, Valerie Mosley, Gregory Smith, Lauren Taylor Wolfe and Barbara Turner resigned from the Board and any committees of the Board on which they served and ceased to be directors of the Company
and Joshua Warren and Thomas Sipp have been appointed as the directors of the Surviving Corporation
and Joshua Warren and Thomas Sipp have been appointed as the directors of the Surviving Corporation
as a result of the Merger, at the Effective Time, each of Luis Aguilar, Gayle Crowell, Valerie Mosley, Gregory Smith, Lauren Taylor Wolfe and Barbara Turner resigned from the Board and any committees of the Board on which they served and ceased to be directors of the Company
On November 22, 2024, the board of directors (the “Board”) of Enzo Biochem, Inc. (the “Company”) appointed Jon Couchman to the Board and to the Board’s Audit Committee, Compensation Committee and Nominating/Governance Committee.
On November 25, 2024, Mr. Jeff Feng Jiang, resigned from his position as a director of the board of directors
the Board accepted Mr. Jiang’s resignation, and appointed Mr. John Chiang as a director of the Company.
On November 19, 2024, the Board of Directors of Klotho Neurosciences, Inc. (the “Company”) appointed Riad El-Dada to the Board of Director to fill a vacancy on the Board of Directors with a term expiring at the Company’s next Annual Meeting of Stockholders.
Susan E. Collins, retired Executive Vice President, Chief Human Resources Officer and Chief Administrative Officer, Tennessee Valley Authority.
On November 23, 2024, Marc Lustig resigned from the board of directors of BriaCell Therapeutics Corp. (the “Company”)
On November 25, 2024, the board of directors of InspireMD, Inc. (the “Board” and the “Company”, respectively) appointed Mr. Scott R. Ward as a Class II member of the Board, effective as of that date, with a term expiring at the Company’s 2025 annual meeting of stockholders.
the Board appointed Dr. Aharon to the Board, effective January 1, 2025.
Warren Thomson 48 Director
Chenlong Liu 35 Director
Hongyu Zhou 36 Director
all of the directors of the Company, namely, Mike Ballardie, Yonah Kalfa, Kirk Taylor, Stephen Crummey, and Rodney Rapson, resigned from the Board of Directors
all of the directors of the Company, namely, Mike Ballardie, Yonah Kalfa, Kirk Taylor, Stephen Crummey, and Rodney Rapson, resigned from the Board of Directors
all of the directors of the Company, namely, Mike Ballardie, Yonah Kalfa, Kirk Taylor, Stephen Crummey, and Rodney Rapson, resigned from the Board of Directors
Kong Liu 35 Director
the Company’s independent directors appointed Mr. Dan Schulman to succeed Mr. Richard D. Parsons, who remains on the Board, as Lead Independent Director of the Company, effective January 1, 2025.
announced today the appointment of Thierry Pilenko, former Executive Chairman of TechnipFMC plc, to its Board of Directors.
on November 21, 2024, the Board of Directors (the "Board’) of the Company appointed Andy Yoo and Seung Ik Baik to the Board.
on November 21, 2024, the Board of Directors (the "Board’) of the Company appointed Andy Yoo and Seung Ik Baik to the Board.
On November 21, 2024, Eui Yull Hwang resigned from the Board for personal reasons, effective immediately as of such date.
On November 21, 2024, Hojoon Lee resigned from the Board for personal reasons, effective immediately as of such date.
On November 22, 2024, Larry Hendricks advised the Board that he would not stand for re-election to the Board at the next annual or special meeting of stockholders at which directors are elected.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.